Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Radioiodine therapy in advanced differentiated thyroid cancer: Resistance and overcoming strategy
Yujia Liu, Jiafeng Wang, Xiao Hu, et al.
Drug Resistance Updates (2023) Vol. 68, pp. 100939-100939
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Bilan Wang, Shiqi Hu, Yan Teng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 87
Global research landscape and trends of papillary thyroid cancer therapy: a bibliometric analysis
Bo Song, Zheyu Lin, Chuyao Feng, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 15
LINC01089 in cancer: multifunctional roles and therapeutic implications
Qiang Yi, Gangfeng Zhu, Xinting Ouyang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Icariin as a potential anticancer agent: a review of its biological effects on various cancers
Fang-Yuan Liu, Dan‐Ni Ding, Yun-Rui Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 12
Radioiodine-refractory differentiated thyroid cancer: Molecular mechanisms and therapeutic strategies for radioiodine resistance
Huize Shen, Rui Zhu, Yanyang Liu, et al.
Drug Resistance Updates (2023) Vol. 72, pp. 101013-101013
Open Access | Times Cited: 12
Investigation of Scutellaria Barbata’s immunological mechanism against thyroid cancer using network pharmacology and experimental validation
Gen Ouyang, Yuangui Zhu, Zhihua Ouyang
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Developing a named entity framework for thyroid cancer staging and risk level classification using large language models
Matrix Man Him Fung, Eric Ho Man Tang, Tingting Wu, et al.
npj Digital Medicine (2025) Vol. 8, Iss. 1
Open Access
GGCT Inhibits Ferroptosis in PTC Cells by Upregulating p53 Through RPS15A
Hui‐min Zhang, Hanning Li, Enbo Qi, et al.
Cancer Science (2025)
Open Access
PIS as a regulator of cellular heterogeneity, prognostic significance, and immune landscape in thyroid cancer
Xianjiang Wu, Lei Dai, Weidong Zhang, et al.
Translational Oncology (2025) Vol. 55, pp. 102296-102296
Closed Access
Consensus Nomenclature for Radionuclide Therapy: Initial Recommendations from Nuclear Medicine Global Initiative
Akram Al‐Ibraheem, Andrew M. Scott, Ahmed Saad Abdlkadir, et al.
Journal of Nuclear Medicine (2025), pp. jnumed.124.269215-jnumed.124.269215
Closed Access
A new therapeutic paradigm: radioiodine combined with lenvatinib for radioiodine-avid metastatic well-differentiated thyroid cancer
Siddharth Sharma, Manish Ora, Prabhakar Mishra, et al.
Nuclear Medicine Communications (2025)
Closed Access
Thyroid cancer: Clinical landscape
Vipul Prajapati, Salona Roy, Yogita Sahu, et al.
Elsevier eBooks (2025), pp. 163-193
Closed Access
Identification of thyroid cancer biomarkers using WGCNA and machine learning
Gaofeng Hu, Wenyuan Niu, Jiaming Ge, et al.
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access
Understanding the Disease Experiences of Thyroid Cancer Survivors with Distant Metastases: A Qualitative Descriptive Study
Kyung Ah Park, Minjin Lee, Sanghee Kim, et al.
European Journal of Oncology Nursing (2025), pp. 102893-102893
Closed Access
Which factors affect treatment success/prognosis in thyroid cancers with pulmonary metastases and what is/how should be the effective cumulative cure/dose as a current approach; A retrospective study
Fatih Tamer, Mertcan Güven, Aylin Oral, et al.
Research Square (Research Square) (2025)
Closed Access
Thyroid cancer and cardiovascular diseases: a Mendelian randomization study
Yamei Gao, Zhijia Wang, Jinsheng Yu, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 3
Novel Platinum(IV) complexes intervene oxaliplatin resistance in colon cancer via inducing ferroptosis and apoptosis
Zhikun Liu, Jinyuan Cai, Guiyang Jiang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 263, pp. 115968-115968
Closed Access | Times Cited: 7
Choice of management strategy for papillary thyroid microcarcinoma: active surveillance or immediate surgery?
Qi Liu, Mingyuan Song, Hao Zhang
Journal of Cancer (2024) Vol. 15, Iss. 4, pp. 1009-1020
Open Access | Times Cited: 2
TIPARP as a prognostic biomarker and potential immunotherapeutic target in male papillary thyroid carcinoma
Jianlin Zhang, Xumin Zhou, Yao Fan, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
How to Manage Advanced Differentiated Thyroid Cancer: Step-by-Step Analysis from Two Italian Tertiary Referral Centers
Paola Sartori, Sara Andreani, Loredana De Pasquale, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 3, pp. 708-708
Open Access | Times Cited: 2
The evolving process of ferroptosis in thyroid cancer: Novel mechanisms and opportunities
Lin Yin, Xiaodan Luo, Xian Zhang, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 16
Open Access | Times Cited: 2
In silicoscreening combined with bioactivity evaluation to identify AMI-1 as a novel anticancer compound by targeting AXL
Linxiao Wang, Yufeng An, Xiongpiao Wei, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 15, pp. 7686-7698
Closed Access | Times Cited: 6
tRF-1:30-Gly-CCC-3 inhibits thyroid cancer via binding to PC and modulating metabolic reprogramming
Bifei Fu, YuMing Lou, Xiaofeng Lu, et al.
Life Science Alliance (2023) Vol. 7, Iss. 3, pp. e202302285-e202302285
Open Access | Times Cited: 4
Research progress of plant-derived natural products in thyroid carcinoma
Qiujing Du, Wei-Dong Shen
Frontiers in Chemistry (2024) Vol. 11
Open Access | Times Cited: 1
[68Ga]Ga-LNC1007 versus 2-[18F]FDG in the evaluation of patients with metastatic differentiated thyroid cancer: a head-to-head comparative study
Yun Chen, Shan Zheng, Jie Zang, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top